Literature DB >> 2143979

[Intravascular ultrasonic diagnosis. In vivo findings before and after angioplasty in peripheral arterial occlusive disease].

G S Werner1, D Corovic, A Buchwald, G Sold, H Kreuzer, V Wiegand.   

Abstract

In 15 patients (13 men, two women, mean age 63 [47-75] years) with peripheral arterial occlusive disease in stages IIB-IV (Fontaine) intravascular ultrasound findings were compared with the angiographic results before and after treatment. In 12 patients stenosis (n = 10) or occlusion (n = 2) of the iliac artery (n = 2) or the superficial femoral artery (n = 10) were treated by conventional balloon angioplasty; in three patients with occlusion of the superficial femoral artery excimer laser angioplasty was performed. There was good correlation between measurements of vessel diameter by the two techniques (r = 0.93, P less than 0.001). Ultrasound scanning provided additional informations regarding the thickness of the plaque, the density or firmness of the stenosis and the degree of calcification. The therapeutic outcome was quantified by measuring the gain in lumen diameter. The authors also assessed the morphological changes following angioplasty in the vicinity of the obstructing plaque. In the light of the ultrasound findings it was considered necessary to undertake further dilatation in four out of the 12 patients treated by balloon dilatation. The results indicate that intravascular ultrasound imaging is a valuable complement to angiography for monitoring of therapeutic results after vascular interventions.

Entities:  

Mesh:

Year:  1990        PMID: 2143979     DOI: 10.1055/s-2008-1065150

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  1 in total

1.  Quantitative assessment of peripheral and coronary artery lesions before and after balloon angioplasty: a comparison of intravascular ultrasound and angiography.

Authors:  M Schartl; W Bocksch; T Linderer; S Beckmann; S Dreysse
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.